Table 1.
Correlation between CD70 expression levels with clinicopathological characteristics in ovarian carcinomas
| Total | CD70 expression | P-value | ||
|---|---|---|---|---|
|
|
||||
| Low | High | |||
| Age | ||||
| <51 years | 36 | 30 | 6 | 0.883 |
| ≥51 years | 56 | 46 | 10 | |
| Grade | ||||
| G1 | 16 | 12 | 4 | |
| G2 | 32 | 26 | 6 | 0.572 |
| G3 | 44 | 38 | 6 | |
| FIGO stage | ||||
| 3 | 67 | 52 | 15 | 0.060 |
| 4 | 25 | 24 | 1 | |
| Level of cytoreduction achieved | ||||
| Optimal | 45 | 38 | 7 | 0.649 |
| Suboptimal | 47 | 38 | 9 | |
| Response to cisplatin-based chemotherapy | ||||
| Resistant | 30 | 19 | 11 | 0.001 |
| Sensitive | 62 | 57 | 5 | |
Abbreviation: FIGO, International Federation of Gynecology and Obstetrics.